These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9619835)

  • 21. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
    Wang SI; Parsons R; Ittmann M
    Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
    Zainuddin N; Jaafar H; Isa MN; Abdullah JM
    Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetic analysis of non-astrocytic gliomas.
    Tong CY; Ng HK; Pang JC; Hui AB; Ko HC; Lee JC
    Histopathology; 1999 Apr; 34(4):331-41. PubMed ID: 10231401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
    Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
    Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic profile of the giant cell glioblastoma.
    Peraud A; Watanabe K; Schwechheimer K; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1999 Feb; 79(2):123-9. PubMed ID: 10068201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is exon 5 of the PTEN/MMAC1 gene a prognostic marker in anaplastic glioma?
    Rustia A; Wierzbicki V; Marrocco L; Tossini A; Zamponi C; Lista F
    Neurosurg Rev; 2001 Jul; 24(2-3):97-102. PubMed ID: 11485247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers.
    Yokomizo A; Tindall DJ; Drabkin H; Gemmill R; Franklin W; Yang P; Sugio K; Smith DI; Liu W
    Oncogene; 1998 Jul; 17(4):475-9. PubMed ID: 9696041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain.
    Furnari FB; Lin H; Huang HS; Cavenee WK
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12479-84. PubMed ID: 9356475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional evaluation of p53 and PTEN gene mutations in gliomas.
    Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C
    Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
    Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
    Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas.
    Sanson M; Leuraud P; Aguirre-Cruz L; He J; Marie Y; Cartalat-Carel S; Mokhtari K; Duffau H; Delattre JY; Hoang-Xuan K
    J Neurosurg; 2002 Dec; 97(6):1397-401. PubMed ID: 12507139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN gene mutations are seen in high-grade but not in low-grade gliomas.
    Rasheed BK; Stenzel TT; McLendon RE; Parsons R; Friedman AH; Friedman HS; Bigner DD; Bigner SH
    Cancer Res; 1997 Oct; 57(19):4187-90. PubMed ID: 9331072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.
    Schmidt EE; Ichimura K; Goike HM; Moshref A; Liu L; Collins VP
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1170-83. PubMed ID: 10560660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The genetic basis of Cowden's syndrome: three novel mutations in PTEN/MMAC1/TEP1.
    Tsou HC; Ping XL; Xie XX; Gruener AC; Zhang H; Nini R; Swisshelm K; Sybert V; Diamond TM; Sutphen R; Peacocke M
    Hum Genet; 1998 Apr; 102(4):467-73. PubMed ID: 9600246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers.
    Kohno T; Takahashi M; Manda R; Yokota J
    Genes Chromosomes Cancer; 1998 Jun; 22(2):152-6. PubMed ID: 9598803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.
    Okami K; Wu L; Riggins G; Cairns P; Goggins M; Evron E; Halachmi N; Ahrendt SA; Reed AL; Hilgers W; Kern SE; Koch WM; Sidransky D; Jen J
    Cancer Res; 1998 Feb; 58(3):509-11. PubMed ID: 9458098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.
    James CD; Galanis E; Frederick L; Kimmel DW; Cunningham JM; Atherton-Skaff PJ; O'Fallon JR; Jenkins RB; Buckner JC; Hunter SB; Olson JJ; Scheithauer BW
    Int J Oncol; 1999 Sep; 15(3):547-53. PubMed ID: 10427138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
    Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
    Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
    Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
    Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.